Unternehmen Briacell Therapeutics Corp Toronto S.E.
Aktien
CA10778Y1043
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01.11.16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01.02.16 |
Chief Tech/Sci/R&D Officer | 53 | 01.05.21 | |
Chief Tech/Sci/R&D Officer | 62 | 16.02.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10.05.16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31.08.21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07.03.18 |
Director/Board Member | 66 | 18.03.19 | |
William Williams
CEO | Chief Executive Officer | 68 | 01.11.16 |
Jane Gross
BRD | Director/Board Member | 67 | 01.11.21 |
Chairman | 39 | 04.02.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 18 284 661 | 15 440 125 ( 84,44 %) | 0 | 84,44 % |
Unternehmenskontakt
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+19,33 % | 125 Mrd. | |
+13,95 % | 109 Mrd. | |
-3,53 % | 24,74 Mrd. | |
+2,71 % | 22,67 Mrd. | |
-9,95 % | 18,14 Mrd. | |
-41,48 % | 16,67 Mrd. | |
-12,62 % | 16,64 Mrd. | |
+0,99 % | 13,45 Mrd. | |
+21,79 % | 11,32 Mrd. |